MedTrace Logo

A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia

NCT07144709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 288

Last updated 2025-08-27

No results posted yet for this study

Summary

This is a prospective, multicentre, non-interventional study, conducted in France and Spain, in primary care practices and designed to assess the QoL of patients under phytotherapy or alpha-blockers for LUTS/BPH. The study will not provide or recommend any treatment or procedure.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DRUG

Phytotherapy

Phytotherapy or alphablockers

Sponsors & Collaborators

  • Kappa Santé

    collaborator INDUSTRY

  • Pierre Fabre Medicament

    lead INDUSTRY

Principal Investigators

  • EID · Pierre Fabre Laboratories

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-22
Primary Completion
2024-07-29
Completion
2024-07-29
FDA Drug
Yes

Countries

  • France
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07144709 on ClinicalTrials.gov